07.45-08.45
Registration of participants
08.45-09.00
Opening remarks
A. Castagna, M. Tinelli
09.00-09.20
Update of epidemiology of multidrug resistance microorganisms in Italy
F. D’Ancona
09.30-10.20
Round Table
Chairs: C. Mussini, R. Parrella
Doctor or robot? The prospects of artificial intelligence in infectious diseases
F. Consolo, R. Murri
10.20-10.40
Place in therapy of antibiotics to treat MDR infections
P. Viale
10.40-11.00
Optimizing antibiotic therapy in intensive care unit
M. Falcone
11.00-11.20
Combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection
G. Tiseo
11.20-11.40
Current and future therapeutic options in invasive mycosis
M. Bassetti
11.50-12.10
The role of broadly neutralizing antibodies in HIV cure
S.G. Deeks
12.10-12.30
Pre-exposure prophylaxis in Italy: where are we?
A. Antinori
12.30-12.50
Present and future of HIV treatment
A. Castagna
13.00-14.00
Poster Session Displayed and on site during the lunch
Phage therapy: state of the art
J.P. Pirnay
14.30-14.50
Arbovirosis: vaccination strategies
E. Nicastri
14.50-15.10
HBV/HDV: current and new antiviral treatments
M. Puoti
15.10-15.30
The added value of monoclonal antibodies in infectious diseases
E. Andreano
15.40-16.00
In bacterial infections
C. Tascini
16.00-16.20
In fungal infections
A. Mularoni
16.20-16.40
In viral infections
C. Muccini